Our January issue is ready!.Featuring monoclonal antibodies for prevention, long-acting injectables, sex differences in #HIV and schistosome co-infection, HIV and healthy cognitive ageing, and more. Also introducing Grace Russell as our 2025 cover artist!.

Read linked comment here:.

One size doesn’t fit all. Cardiovascular risk scores may not tell the full story for people with #HIV worldwide. REPRIEVE data shows accuracy disparities by region, sex, and race. Read it here:

RT @UNAIDS: With sufficient investments in the HIV response & the UNAIDS Joint Programme, we can achieve viral load suppression targets in….

@E_Cordova79 Read linked comment here:.

No baseline test, same efficacy. D2ARLING study supports use of dolutegravir + lamivudine for #HIV therapy in settings with limited testing access and low frequency of transmitted drug resistance to lamivudine or integrase inhibitors. @E_Cordova79 .

Read linked comment here:.

Real-world setting confirms long-acting injectable cabotegravir plus rilpivirine is a durable and effective treatment for well-suppressed people with #HIV. Risks seem to remain for those with previous virological failure or unsuppressed at ART initiation.

RT @TheLancet: Global HIV rates are rising among people aged 50 and older, generating increasing awareness about the importance of brain he….

Our January editorial ponders on the future of USA domestic and global #HIV responses under the upcoming new USA administration.

Read linked comment here:

Evidence-based interventions drive success in #HIV epidemic control. Lesotho cut HIV incidence by half between 2016–2020, boosted viral suppression to 91%, and increased ART coverage to 97%; nearing the 95-95-95 #UNAIDS targets. @ICAP_ColumbiaU.

Can respect and kindness in healthcare improve #HIV outcomes? This trial in Zambia found person-centred care boosts retention, reduces missed visits, and transforms client experiences, although did not relate to improval on treatment success.

To finish the year, a podcast for our Spanish speaker listeners:.Entrevistamos a Claudia Cortes (@cla_cor) and Giovanni Ravasi sobre los desafíos a los que se enfretan las personas migrantes en el marco de la prevención y el tratamiento del VIH.

Our last issue of the year is out! Featuring a Series of articles on migration and #HIV, the latest data on global burden of HIV, disruption of HIV services during extreme weather events and harm-reduction programmes in South Africa. Read it here: .

RT @WHO: Prevention empowers and protects. 💪❤️. Access to HIV prevention tools, education, & services safeguards health and upholds rights.….

RT @TheLancet: Despite encouraging progress in the global #HIV effort, the Sustainable Development Goal of ending HIV as a public health th….

@UNAIDS @IHME_UW @UW The Authors set a series of recommendations to sustain and invigorate the global HIV response, including strengthening the U.S @PEPFAR and other similar public health programs dedicated to HIV control and expansion of prevention services worldwide.

@UNAIDS @IHME_UW @UW Decline in HIV incidence is largely driven by sub-Saharan Africa, but HIV is on the rise in central/eastern Europe and central Asia, where probability of HIV acquisition increased by 586.4% (1995 vs 2021) and prevalence of unsuppressed viraemia increased by 116.1% (2003 vs 2021)

Latest estimates of global burden of HIV/AIDS between 2010 and 2021 show new #HIV infections fell by 22% and HIV-related deaths fell by 40%, but current trends indicate the world is not on track to meet the @UNAIDS 2030 targets. @IHME_UW @UW.Read it here:.